1966
DOI: 10.1016/s0140-6736(66)91573-x
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Chronic Portal-Systemic Encephalopathy With Lactulose

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

1976
1976
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 76 publications
(19 citation statements)
references
References 7 publications
0
19
0
Order By: Relevance
“…Lactulose can improve the life quality of people suffering from hepatic encephalopathy. This prebiotic also has preventive effects on hepatic encephalopathy [143,168,169,170]. Lactulose exerts its beneficial effects on hepatic encephalopathy through different pathways.…”
Section: Prebiotics Mechanisms For Health Maintenance and Protectimentioning
confidence: 99%
“…Lactulose can improve the life quality of people suffering from hepatic encephalopathy. This prebiotic also has preventive effects on hepatic encephalopathy [143,168,169,170]. Lactulose exerts its beneficial effects on hepatic encephalopathy through different pathways.…”
Section: Prebiotics Mechanisms For Health Maintenance and Protectimentioning
confidence: 99%
“…Accordingly, direct elimination of ammonia from the gut via purgatory treatments and reduction of proteolytic bacterial flora, as well as reduction of inflammation secondary to gut translocation of bacterial by-products, form the mainstay of HE therapy. Nonabsorbable synthetic disaccharides, such as lactulose and lactitol, were first introduced in 1966 50 and constitute first-line therapy for HE. 1 Their mechanism of action is likely multifactorial.…”
Section: Article Highlightsmentioning
confidence: 99%
“…The result is acidification of colonic contents and variable diarrhea, depending upon lactulose dosage. In 1966 Bircher et al56 described the first use of lactulose to treat hepatic encephalopathy in CLD – the encephalopathy of two of three patients appeared to respond in an uncontrolled study. The stated rationale was the belief that a colonic acidic acid environment reduces the bacterial production of putative neuro toxins, one of which is ammonia.…”
Section: Mechanisms Of Action Of Lactulose and Rifaximinmentioning
confidence: 99%